Good Outcomes, Little Hospital Experience: Pascal TEER in Real World
The study led to questions about whether patients would be best served by being treated at high-volume centers of excellence.
The study led to questions about whether patients would be best served by being treated at high-volume centers of excellence.
About 8% of all adults age 18 and older—more often men than women—received some treatment for heart disease in 2022.
The Intrepid TMVR system just released 2-year transfemoral EFS outcomes at NY Valves. This discussion provides a deeper dive into what this data means for…
Declines in moderate-to-vigorous exercise start in midlife, then speed up before diagnosis—raising opportunities to intervene.
The AF population is sicker than those in sinus rhythm and needs more attentive care, both before and after the procedure.
When considering lead replacement, physicians should weigh the risks and benefits of extraction versus abandonment.
TCTMD journalists discuss their favorites of the month: from the latest data to summer adventures.
Myocardial fibrosis is independently associated with the onset of ventricular arrhythmia in male veteran endurance athletes.
The Intrepid TMVR system just released 2-year transfemoral EFS outcomes at NY Valves. This discussion provides a deeper dive into what this data means for…
TCTMD: the most comprehensive online resource for interventional cardiology and beyond, with news coverage spanning the entire field of cardiovascular disease.
Despite an increase in the conversion factor, slashed payments elsewhere could amount to “death by a thousand paper cuts.”